4.6 Review

Management of Impulse Control Disorders in Parkinson's Disease: Controversies and Future Approaches

期刊

MOVEMENT DISORDERS
卷 30, 期 2, 页码 150-159

出版社

WILEY
DOI: 10.1002/mds.26099

关键词

Parkinson's; Impulse control; Management; Dopamine Agonist Withdrawal; Deep Brain Stimulation; Clinical Trials

资金

  1. Movement Disorders Society (USA)
  2. National Institute of Health (USA) [U13NS080495]
  3. Parkinson's Disease Foundation (USA)
  4. Parkinson's UK
  5. Parkinson's Disease Society (Canada)
  6. AbbVie Ltd
  7. UCB
  8. St Jude Medical Limited

向作者/读者索取更多资源

Impulse control disorders in Parkinson's disease are a group of impulsive behaviors most often associated with dopaminergic treatment. Presently, there is a lack of high quality evidence available to guide their management. This manuscript reviews current management strategies, before concentrating on the concept of dopamine agonist withdrawal syndrome and its implications for the management of impulse control disorders. Further, we focus on controversies, including the role of more recently available anti-parkinsonian drugs, and potential future approaches involving routes of drug delivery, nonpharmacological treatments (such as cognitive behavioral therapy and deep brain stimulation), and other as yet experimental strategies. (c) 2015 International Parkinson and Movement Disorder Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据